March 20, 2023
32nd Annual King & Spalding Health Law & Policy Forum
March 8, 2023
California Life Sciences Summit
February 23, 2023
MDLs: Judges, Defendants and Plaintiffs Too – Who Is Buzzing About What?
January 25, 2023
Eva Temkin to Speak on Food and Drug Law Institute Webinar
January 24, 2023
Year in Review for Drug and Device Advertising and Promotion: Lessons Learned From 2022 FDA Enforcement Letters and Other Key Developments
January 19, 2023
A New Year, A New Day - What’s Next for Healthcare Policy and Oversight in the New Congress
December 16, 2022
Ulf Grundmann, Elisabeth Kohoutek to Speak at Hebrew University of Jerusalem’s BioMED MBA Program
December 8, 2022
Physician Practice Acquisitions Roundtable: Considerations for Negotiating on Behalf of Buyers and Sellers
December 2, 2022
Ulf Grundmann to Speak at Frankfurt School of Finance and Management’s International Healthcare Management MBA Program
November 30, 2022
Lisa Dwyer to Speak on Food and Drug Law Institutes Virtual Event
November 30, 2022
Are You Prepared? FDA’s Proposed Rules to Modify Protection of Human Subjects and IRB Oversight
November 17, 2022
State Attorneys General Election Results and What to Expect in 2023